Stephen P. Creekmore

Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

Kevin C. Conlon, Enrico Lugli, Hugh C. Welles et al. · Journal of Clinical Oncology · 2014 · 686 citations · Full text

Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma

Maurizio Bendandi, Christopher D. Gocke, Carol B. Kobrin et al. · Nature Medicine · 1999 · 591 citations

Vaccination, Lymphoid Neoplasia, Tumor Immunology +12

A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma.

Janice P. Dutcher, Stephen P. Creekmore, Geoffrey R. Weiss et al. · Journal of Clinical Oncology · 1989 · 236 citations

Lak Cells, Immunology, Immunoediting +18

Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques

Thomas A. Waldmann, Enrico Lugli, Mario Roederer et al. · Blood · 2011 · 191 citations · Full text

Alterations in T cell receptor and signal transduction molecules in melanoma patients.

Arnold H. Zea, Brendan D. Curti, Dan L. Longo et al. · PubMed · 1995 · 191 citations

T-regulatory Cell, Immunology, Pathology +16